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We evaluated the antioxidative and anti-inflammatory potential of daily oral 
supplementation with a proprietary powdered Cucumis melo pulp (CMP) 
on exercise-induced markers of articular and muscular oxidative stress and 
inflammation in 12 horses. Horses performed a high-intensity exercise test 
immediately prior to, and then following, 3 weeks of daily supplementation 
of 1 g powdered CMP (CMP; n=8). Controls (Co; n=8) underwent the same 
exercise and sampling regime but were not supplemented. Blood and syno-
vial fluid (SF) samples were taken 24 h prior to exercise (BL), and at 1 and 
24 h following exercise. Plasma and SF were analysed for prostaglandin 
E2 (PGE2), total antioxidant status (TAS), nitrite and superoxide dismutase 
(SOD) activity. SF was analysed for glycosaminoglycans (GAG), and 
plasma was analysed for thiobarbituric acid reactive substances (TBARS). 
Comparisons were made using repeated measures with the initial exercise 
test as a covariate. There was an increase in SF SOD activity in the CMP 
group. Compared to Co at 1 h, CMP reduced nitrite and GAG in SF, as well 
as maintained plasma TAS and lymphocyte levels. At 24 h, plasma PGE2 
and creatine kinase were lower in horses receiving CMP. Three weeks of 
supplementation with CMP reduced markers of articular and skeletal mus-
cle oxidative stress and inflammation in response to high-intensity exercise 
in horses. Nutritive antioxidants may provide a useful adjunct to the daily 
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Abbreviations
A:G ratio  albumin:globulin ratio
ALB   albumin
AST   aspartate aminotransferase
BL   baseline
CK  creatine kinase
CMP   Cucumis melo pulp powder
Co   control
Cre   creatinine
GAG  glycosaminoglycans
HGB   hemoglobin
IU   International Units
LYM   lymphocytes
NRC   National Research Council
PGE2  prostaglandin E2
RBC   red blood cells
ROS   reactive oxygen species
SF   synovial fluid
SOD   superoxide dismutase
TAS   total antioxidant status
TBARS  thiobarbituric acid reactive substances.
1. Introduction
Horses that have performed moderate to high intensity exercise experience increased mito-chondrial production of reactive oxygen spe-
cies (ROS; oxygen free radicals) within muscle [1,2]. An 
accumulation of ROS appears to be a key contributor 
to the inflammatory response to intense exercise that is 
evident both in muscle [2] and in blood [1-7]. In horses, the 
magnitude and duration of oxidative stress markers in 
plasma and synovial fluid was proportional to the exer-
cise intensity and duration [3,7,8]. One of the first studies 
to relate performance to inflammation was that of Davis 
et al. [9] using humans, in a trial where curcumin was 
provided as a nutritive antioxidant. Similar results were 
recently demonstrated when people consumed quercetin 
for 14 days [10]. Improved performance has also been 
shown to be a sequalae of reduced muscle damage [11], 
inferring that inflammation is associated with decreased 
performance. Yang et al. [12] showed within-game deteri-
oration of performance has also been directly associated 
with increased muscle inflammation. Tanabe et al. [13] 
demonstrated that dietary curcumin attenuates acute in-
flammation and muscle damage and could facilitate fast-
er recovery. Taken together, these results demonstrated 
that the inflammation associated with the oxidative stress 
of exercise can impair performance and rate of recovery 
from normal exercise training bouts [14,15].
Within the joints, the stress of exercise training or 
conditioning is also often associated with increased ROS 
within synovial fluid and inflammation around and within 
the joints [16]. This is evidenced by elevated levels of sy-
novial fluid markers of oxidative stress and inflammation 
such as prostaglandin E2 (PGE2) 
[17,18]. Excess production 
of ROS (such as superoxide and hydrogen peroxide) with-
in joints directly contributes to the inflammation [17,19,20]. 
While a mild inflammation may be deemed a normal part 
of the beneficial adaptive responses to exercise, excessive 
inflammation contributes to muscle and joint pain, further 
tissue degeneration, and impaired exercise performance 
and wellness [21,22].
The incidence of degenerative joint disease, eventually 
leading to clinical osteoarthritis (OA), is high in young 
performance horses, often at a time when these athletes 
should be at the peak of their careers [2,8]. Increasingly, 
veterinarians, owners and trainers are using dietary or nu-
tritive antioxidant supplements to mitigate inflammation 
associated with excess oxidative damage [23]. The dried 
and powdered pulp of a particular non-GMO straina of 
Cucumis melo LC (cantaloupe or muskmelon) is rich in 
the antioxidant enzymes superoxide dismutase (SOD) 
and catalase [24-26] and has been shown to provide protec-
tion against administered pro-inflammatory compounds 
[25]. This C. melo pulp (CMP) also reduced markers of 
oxidative stress and improved antioxidant activity in hu-
mans [27], pigs [28], felines [29], mice [30] and horses [31]. In a 
recent study CMP was one of the ingredients in an oral 
supplement for horses that performed the same study as 
described herein [23]. They also reported reductions in the 
markers of muscle and synovial fluid oxidative stress and 
inflammation.
The objective of the current study was to investigate if 
CMP, one of the ingredients used in the previous study [23] 
was associated with antioxidant and anti-inflammatory ef-
fects when fed daily to horses for 3 weeks. It was hypoth-
esized that CMP will result in reduced signs of muscle 
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by the Nutraceutical Alliance Animal Care Committee 
(Campbellville, ON, Canada) prior to the beginning of 
this study in accordance with the Ontario Animals for 
Research Act and the Canadian Council on Animal Care 
guidelines. All horses were privately owned, and written 
informed consent was obtained from each owner prior to 
the start of the study.
2.2 Experimental Animals
Twelve horses of mixed breed, gender (6 mares, 6 geld-
ings), and age (range 5 - 17, median 7.5) participated in 
this study (Table 1). Stratified assignment of horses to 
groups was performed so that groups were as uniform as 
possible according to body mass, body condition score, 
age, sex, breed and age. All horses were clinically normal 
and underwent weekly health checks which consisted of 
checking rectal temperature, heart rate, respiratory rate, 
hydration (by skin pinch), menace reflex, and gut sounds. 
Health checks were also performed on all horses within 
24 h prior to each sampling day. All horses had no known 
veterinary history of chronic joint inflammation or lame-
ness and were visibly sound on exercise days using the 
American Association of Equine Practitioners lameness 
exam scoring system. Prior to participation in the study, 
and during the study, all horses maintained a regular 
schedule of pleasure riding and light lessons. Horses were 
randomly assigned to a diet containing either 0 (Co; n=8) 
or 1 g (CMP; n=8) in their morning feed, based on the 
manufacturer’s instructions. The supplement dosage was 
therefore in the range of 1.55 to 2.14 mg / kg body mass 
per day. The supplement provided approximately 2600 
IU SOD per horse/day according to the manufacturer. 
All horses were fed a diet which met their nutritional re-
quirements [32] and were housed at the same facility in a 
loose-housing system, with unlimited access to shelter, 
pasture, hay and water.
Table 1. Description of horse breed, age, gender, treat-
ment, and round for control (Co, n=8) and supplemented 
(CMP, n=8) horses used in the current study
Horse Breed Gender Age, yr
initial, final 
mass (kg) Group Round
1 Thoroughbred Gelding 8 467, 477 Co 1
2 Quarter horse Mare 5 565, 566 Co 1
3 Dutch warm-blood Mare 5 585, 583 Co 1
4 Thoroughbred Mare 13 571, 582 Co 2
5 Morgan Gelding 16 504, 516 CMP 1
6 Oldenburg Mare 7 591, 584 CMP 2
7 Quarter horse Gelding 7 579, 585 CMP 3
8 Thoroughbred Gelding 13 473, 466 CMP 3
9 Morgan Gelding 17 506, 496 Co, CMP 2,1
10 Quarter horse / Haflinger Mare 5 501, 508
Co, 
CMP 2,3
11 Thoroughbred Gelding 7 541, 542 Co, CMP 2,1
12 Quarter horse Mare 8 645, 647 Co, CMP 3,2
2.3 Test Material
The test material was a 1 kg sample of a fresh batch of 
CMP provided by Lallemand Animal Nutrition in a sealed 
vacuum pouch (registered as Melofeed® in Europe and as 
EnzaloxTM in North America; Lallemand Animal Health, 
Montreal, Canada). The pouch was opened on the first day 
it was to be used as a supplement to the feed, and thereafter 
maintained in a sealed plastic container in a refrigerator (6 
– 10oC). The dry, powdered product is stable for at least 2 
years when maintained under these conditions. This sample 
provided adequate supplement for the entire study.
2.4 Study Design
This study was part of a larger 3-way crossover design [23] 
that was conducted over 3 rounds (Fig. 1); horses partic-
DOI: https://doi.org/10.30564/vsr.v2i1.1559
Figure 1. Schematic representation of the experimental schedule
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ipated in a control round, a CMP round, and a round for 
another nutraceutical treatment with a 25-day duration for 
each round. Only the person feeding the horses knew if 
which horses received supplement, and horse owners were 
also blinded to the treatment, by consent. Each round con-
sisted of a covariate sampling period, a dosing period, and 
a treatment sampling period. For each round, a high-in-
tensity exercise test was performed on day 1 (covariate 
sampling period), followed by 23 days of supplementa-
tion (or placebo) provided in the morning meal (dosing 
period), and a second exercise test on day 22 (treatment 
sampling period). The purpose of the day 1 exercise test 
was to serve as a time-based control, as well as provide a 
baseline. This was incorporated into the statistical analysis 
as a covariate. Horses maintained their usual activity and 
training level for the entire duration of their participation 
in the study. Rounds were separated by a 3-wk washout 
period to minimize nutritional, biochemical and physio-
logical carryover effects [33-35]. The order of the treatments 
was randomized across the cohort of horses (Table 1). 
By design, it was intended that each horse was to com-
plete each of three treatments trials: control, CMP and a 
blended product of which the results have already been 
reported [23]. However, as in most moderate-duration field-
type studies, and particularly those with a high intensity 
exercise component with repeated arthrocentesis, there 
was some attrition of horses that started. It is important, 
physiologically and psychologically, that horses are calm 
and easily manageable for all procedures, else anxiety will 
be a major confounder of physiological variables. Thus, 
the first two rounds consisted of 6 horses per round (3 Co, 
3 CMP), and the last round consisted of 4 horses (2 Co, 2 
CMP), due to subject attrition unrelated to the study (see 
Table 1). Of the 12 horses, 4 participated in the control 
group (Co), 4 participated in the CMP group (CMP), and 
4 participated in both (Co and CMP).
2.5 Exercise Test
Horses were exercised under saddle in groups of 2 or 3 
matched according to speed and fitness at approximately 
11 am. Three riders were used, of similar body mass (+/- 
10 kg) and riding experience (competent, non-profession-
al). Ambient conditions were dry, with relative humidity 
50 and 70% and temperature 14 – 22o C. Heart rate was 
monitored during galloping by the riders using equine 
heart rate monitors (Polar Electro Canada, Lachine, QC, 
Canada). Horses were warmed up (at the walk, trot, and 
canter) for 20 min prior to the exercise test. The exercise 
test consisted of repeated single-lap gallops around a dry 
½ mile dirt track at a target heart rate of 180 bpm, sepa-
rated by approximately 4 min of walking until heart rates 
decreased to approximately 100 bpm [36]. This process was 
repeated for 2-3 more laps (depending on the ability of the 
horse) until the horse’s time around the track increased by 
10% of their fastest lap. The first exercise test sequence 
performed by each horse was used to determine their 
maximal heart rate, speed, and ability. The mixed breed 
horses were able to complete 3 laps while the Thorough-
breds completed four. The number of laps was conserved 
for each horse for the subsequent exercise tests.
2.6 Sample Collection
Samples were obtained at baseline (BL), around 11 am 
the day prior to each of the exercise tests, then again at 1 
and 24 h following the cessation of exercise. Timing of 
sampling was determined in a previous study that exam-
ined the time course of inflammation and oxidative stress 
markers in response to high intensity exercise in horses [36].
An area approximately 4 X 5 cm was clipped around 
the blood sampling site (left jugular groove), and synovial 
fluid sampling sites (the medial side of the left and right 
intercarpal joints) to reduce hair length to less than 2 mm. 
Topical anesthetic (Emla cream, 2.5% lidocaine, 2.5% 
prilocaine; AstraZeneca, Mississauga, ON, Canada) was 
applied to the clipped area approximately 30 min prior to 
sampling. Blood samples were collected directly into so-
dium heparin and EDTA-vacutainer tubes (Becton-Dick-
son, Mississauga, ON, Canada) from the jugular vein 
using a 21G 1.5” multiple sample needle (Becton-Dickson, 
Mississauga, ON, Canada). Blood samples were taken im-
mediately prior to arthrocentesis and chilled on ice until 
processing, which occurred within a 2 h period.
Aseptic arthrocentesis was performed at each time 
point, alternating joints between samples to allow suffi-
cient time for replenishment of SF. The left or right in-
tercarpal joint was prepared using a stanhexidine / iodine 
scrub followed by 99% isopropyl alcohol. Approximately 
1 mL of fluid was aspirated using a 22 G x 1” needle into 
a 3 cc sterile syringe. Aspirated fluid was immediately 
transferred into a sodium heparin vacutainer tube and 
chilled on ice until processing, which occurred within 2 h.
2.7 Sample Processing
Fresh blood samples were analyzed for biochemistry 
[albumin (ALB), albumin/globulin ratio (A:G), aspartate 
amino transferase (AST), creatinine (Cre), creatine kinase 
(CK)] (Johnson & Johnson, Ortho Clinical Diagnostics 
Model 5.1 Fusion) and complete blood count (Siemens 
Model Advia 2120, Nassagaweya Veterinary Laboratory 
Services, Campbellville, ON, Canada). Additional aliquots 
of heparinized blood and SF were centrifuged at 6000 x g 
DOI: https://doi.org/10.30564/vsr.v2i1.1559
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for 15 min. Supernatant was then transferred into Eppen-
dorf tubes and stored at -20ºC until analysis.
Prior to analysis, SF samples were digested via hyalu-
ronidase treatment to improve assay precision [37]. Hyalu-
ronidase (Sigma-Aldrich, Oakville, ON) was suspended in 
PBS to a final concentration of 4 mg/ml solution. SF sam-
ples were prepared using a 1:1 dilution of hyaluronidase 
solution and sample. Mixed hyaluronidase:SF samples 
were agitated for 1 h, centrifuged at 1000 x g for 5 min, 
and the supernatant was removed and used in assays.
2.8 Sample Analyses
Samples were analysed for nitrite (Griess Reaction, Mo-
lecular Probes, Eugene OR), total antioxidant status (TAS; 
Cayman Chemical, Ann Arbor, MI), superoxide dismutase 
(SOD; Trevigen, Gaithersburg, MD), and prostaglandin E2 
(PGE2; DetectX Prostaglandin E2 Enzyme Immunoassay, Ar-
bor Assays, Ann Arbor, MI). Plasma was analysed for thio-
barbituric acid reactive substances (TBARS; R&D Systems 
Inc., Minneapolis, MN), and untreated SF was analysed for 
glycosaminoglycans (GAG) [38] as detailed previously [20].
Table 2. Time, treatment, and treatment by time effects within plasma markers of oxidative stress and inflammation, as 
well as blood biochemistry and hematology parameters in response to high-intensity exercise in control (Co; n=8) and 
supplemented (CMP; n=8) horses
BL 1 h 24 h ptime ptrt ptrt*time
SF
SOD IU/ml
Co 166 ± 13.0 170 ± 13.0 187 ± 13.0 0.4 0.04 0.7
CMP 183 ± 13.0 204 ± 13.0 198 ± 13.2
PGE2 pg/ml
Co 196 ± 31.6 227 ± 32.1 163 ± 31.6 0.04 0.3 0.2
CMP 171 ± 30.8 144 ± 30.5 128 ± 30.5a
Plasma
TAS mM
Co 1.09 ± 0.023a 0.97 ± 0.023b* 1.06 ± 0.024ab 0.004 0.1 0.1
CMP 1.07 ± 0.022 1.04 ± 0.024 1.09 ± 0.023
Blood
A:G
Co 0.92 ± 0.035 1.04 ± 0.053 0.91 ± 0.044 0.004 0.6 0.8
CMP 0.96 ± 0.033 1.04 ± 0.051 0.93 ± 0.043
ALB, g/dL
Co 31.4 ± 0.54 34.8 ± 1.65 31.9 ± 0.64 0.0062 0.6 0.3
CMP 32.2 ± 0.53ab 36.3 ± 1.62a 31.6 ± 0.65b
AST, µmol/L
Co 342 ± 25.8 399 ± 34.2 490 ± 74.2 0.013 0.7 0.4
CMP 401 ± 26.1 417 ± 33.2 468 ± 71.0
CRE, U/L
Co 117 ± 5.0a 137 ± 5.5b 119 ± 5.0a <0.0001 0.9 0.7
CMP 114 ± 4.8a 139 ± 5.0b 121 ± 5.0a
HGB, g/L
Co 13.7 ± 0.55a 16.0 ± 0.59b 15.3 ± 0.55b 0.0005 0.7 0.4
CMP 14.0 ± 0.54a 15.9 ± 0.55b 14.5 ± 0.55ab
RBC, 1012/L
Co 8.1 ± 0.29a 9.6 ± 0.33b 9.0 ± 0.29ab 0.0004 0.4 0.6
CMP 8.1 ± 0.30a 9.3 ± 0.29b 8.5 ± 0.30ab
LYM, 109/L
Co 2.9 + 0.30a 4.8 + 0.30a 3.0 + 0.30a < 0.006 0.002 0.01
CMP 3.0 + 0.28 3.3 + 0.30* 3.3 + 0.30
Marker concentrations are means ± SEM. BL = baseline sample taken approximately 24 h prior to the exercise test; 
SOD = superoxide dismutase; TAS = total antioxidant status; A:G = albumin to globulin ratio; ALB = albumin; AST = 
aspartate aminotransferase; CRE = creatinine; HGB = hemoglobin; RBC = red blood cells; LYM = lymphocytes.
Notes: ab Superscripts which differ denote significantly different values within treatment (p≤0.05).
* Denotes a significant difference between Co and CMP at the particular timepoint (p≤0.05).
DOI: https://doi.org/10.30564/vsr.v2i1.1559
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2.9 Statistical Analysis
Data are presented as mean ± SEM unless otherwise stat-
ed. Data were analyzed with respect to pre- vs post-sup-
plementation / placebo within each group, exercise time 
points, and trial using analysis of variance (ANOVA). 
Marker concentrations (Yijk) were subject to repeated 
measures ANOVA (PROC MIXED University Edition, 
SAS Institute Inc.) according to the following model:
Yijk = µ + β×initial + trti + timej + trt*timeij + ɛijk
where µ = overall mean, β = the covariate slope, initial 
= marker concentration during the covariate sampling 
period, trt = fixed effect of treatment (i = Co or CMP), 
time = repeated measure of time (j = 1 to 3) and ɛijk = the 
experimental error. Comparisons were also made between 
treatments at each sampling time using estimate state-
ments. Least square means using a Tukey adjustment were 
employed to analyse the effects of time within group. 
Significance was set at P ≤ 0.05. In the description of the 
results the term ‘time effect’ therefore indicates that the 3 
weeks of supplement resulted in an effect that can be, and 
has been, attributed to the supplement. The term ‘treatment 
effect’ refers to differences between the control group and 
the treatment group at the second time point (end of trial). 
3. Results
3.1 SF Markers of Oxidative Stress
No effects were observed for SF TAS (Table 2). There 
was an effect of trial duration on SOD activity, which was 
lower at the end of the trial period before exercise in the 
control trial but not the CMP trial (data not shown). There 
was an effect of treatment for SF SOD, with consistently 
higher SF SOD in the CMP group than the Co group (p = 
0.04, Table 2).
3.2 SF Markers of inflammation
There were no effects of trial duration on SF markers of 
inflammation (pre-exercise comparisons). SF PGE2 was 
significantly lower at 24 h post exercise in CMP resulting 
in an overall time effect (p = 0.04, Table 2). There were no 
significant differences between treatments at 1 h post-exer-
cise (227 ± 32.1 pg/ml in Co vs 144 ± 30.5 pg/ml in CMP; 
p = 0.09). There was an effect of time for SF fluid nitrite (p 
= 0.04). Nitrite was lower in CMP (9 ± 7.7 µM) compared 
to Co (39 ± 7.7 µM) at 1 h (p = 0.01, Figure 2). Synovial 
fluid GAG was lower in CMP (344 ± 155 µg/ml) compared 
to Co (820 ± 130 µg/ml) at 1 h (p = 0.03, Figure 3).
Figure 2. Mean ± SEM of synovial fluid (SF) nitrite (µM) 
in control (Co; n=8) and supplemented (CMP; n=8) horses 
24 h prior to (BL), at 1 and 24 h following, a standardized 
high-intensity exercise test
Note: * Denotes significant difference between the Co and CMP (p≤0.05).
Figure 3. Mean ± SEM of synovial fluid (SF) glycosami-
noglycans (GAG; µg/ml) in control (Co; n=8) and supple-
mented (CMP; n=8) horses 24 h prior to (BL), at 1 and 24 
h following, a standardized high-intensity exercise test 
Note: * Denotes significant difference between the Co and CMP (p≤0.05).
3.3 Plasma Markers of Oxidative Stress
There were no effects of trial duration on plasma markers 
of oxidative stress (pre-exercise comparisons). There was 
an effect of time on plasma TAS (p = 0.004), and in the 
Co plasma TAS was lower compared to BL at 1 h (p = 0.01) 
and compared to CMP at 1 h (p=0.03, Table 2).
3.4 Plasma Markers of Inflammation
There were no effects of trial duration on plasma markers 
of inflammation (pre-exercise comparisons). Plasma PGE2 
was reduced in CMP (128 ± 30.5 pg/ml) compared to Co 
(163 ± 31.6 pg/ml) at 24 h (p = 0.04, Figure 4). 
DOI: https://doi.org/10.30564/vsr.v2i1.1559
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Figure 4. Mean ± SEM of plasma prostaglandin E2 (PGE2; 
pg/ml) in control (Co; n=8) and supplemented (CMP; 
n=8) horses 24 h prior to (BL), at 1 and 24 h following, a 
standardized high-intensity exercise test
Note: * Denotes significant difference between the Co and CMP (p≤0.05).
3.5 Markers of Blood Biochemistry
Time effects were observed for CRE, AST, ALB, A:G 
ratio, HGB, and RBC (Table 2). There was an effect of 
treatment (p = 0.02) and time (p = 0.02) for CK. In the Co 
CK was higher compared to BL at 24 h (665 ± 73.0 U/L 
vs 295 ± 76.8 U/L; p = 0.03) and CMP at 24 h (353 ± 77.6 
U/L; p = 0.008, Figure 5).
Figure 5. Mean ± SEM of creatine kinase (CK; U/L) in 
control (Co; n=8) and supplemented (CMP; n=8) horses 
24 h prior to (BL), at 1 and 24 h following, a standardized 
high-intensity exercise test
Notes: Lines connect significantly different time points within the Co.
* Denotes significant difference between the Co and CMP (p≤0.05). 
3.6 Markers of Immunity
Time (p = 0.004) and time by treatment (p = 0.01) effects 
were observed for blood lymphocytes (Table 2, LYM). 
In the Co, LYM was elevated at 1post-exercise, and this 
response was not observed in the CMP trial. In the CMP 
trial, there was no effect of exercise on the LYM response. 
There were no changes in any of the other hematological 
variables.
4. Discussion
This study provides evidence that dietary CMP behaved 
as a nutritive antioxidant and influenced the systemic and 
articular environment in horses undergoing and recov-
ering from intense exercise. Given that muscle mass is 
about 40% of body mass, and the largest single tissue in 
the body [39] and that the horses exercised at high intensi-
ty using muscle, the systemic responses observed in the 
present study can only be attributed to skeletal muscle. 
Horses supplemented with CMP displayed attenuation of 
post-exercise increases in SF nitrite and GAG, as well as 
evidence of diminished plasma PGE2 and CK. These re-
sults are consistent with reductions of oxidative stress and 
inflammation in joints and skeletal muscle after high in-
tensity exercise. The results also confirm that antioxidant 
and anti-inflammatory responses observed in the equine 
joint oral supplement reported previously [23] may be at-
tributed in part to CMP.
There was a general absence of effect of CMP sup-
plementation on measures obtained at rest (pre-exercise 
samples on day 1 compared to pre-exercise on day 22). 
This suggests that in the absence of a measurable oxida-
tive stress a physiological or biochemical adaptation to 3 
weeks of supplementation was not readily apparent. The 
observed time effects in blood variables are consistent 
with physiological changes due to high-intensity exercise 
[7,36,40] indicating that the standardized exercise test was of 
suitable intensity and physiological stress. Additionally, 
in Co horses, plasma TAS was reduced 1 h following the 
exercise test indicating that the exercise was of sufficient 
intensity to tax and diminish antioxidant systems. Short 
intense bursts of physical effort in horses [3,5,40], endur-
ance exercise in dogs [41] and horses [8,42], acute bouts of 
treadmill exercise in rats [43] and high-intensity leg cycling 
exercise in healthy adult humans [44] have also resulted in 
decreased plasma TAS.
In contrast, following 23 days of CMP the maintenance 
of plasma TAS at 1 h post-exercise suggests a reduction of 
oxidative damage, inflammation, and muscle membrane 
injury (evidenced by reduced plasma PGE2 and CK 24 h 
following exercise). A nutritive antioxidant that mitigates 
excessive oxidative stress and inflammation [2,6,20,45] is ap-
pealing for endurance horses and horses that are required 
to compete for multiple days. However, care must be tak-
en to also allow normal muscle repair and growth mecha-
nisms to occur [46].
DOI: https://doi.org/10.30564/vsr.v2i1.1559
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Lymphocyte concentrations and plasma TAS were 
maintained at baseline levels in CMP supplemented hors-
es 1 h post-exercise, in contrast to the elevation seen at 
1 h post-exercise in Co. Within the Co group, TAS was 
significantly decreased at the 1 h time point compared to 
BL. While there were no overt effects of CMP supplemen-
tation in horses at rest (pre-exercise comparison 22 days 
apart) CMP supplementation appears to have assisted in 
maintaining blood antioxidant potential and this became 
evident in response to the oxidative stress imposed by 
high intensity exercise. The mechanism is unclear as 
plasma SOD activity was unchanged in the CMP group, 
but perhaps indicating that activity was adequate for the 
demands. It is also possible that upregulated activities of 
glutathione peroxidase or catalase may have contributed 
to the increase in plasma TAS [25,47], and this needs to be 
investigated in future studies.  
Ingestion of encapsulated forms of CMP reportedly 
mitigates the severity of diabetic neuropathy [26] and bio-
markers associated with exercise stress [48]. The CMP is 
made from a melon with naturally very high SOD and 
catalase activities [26,49]. After ingestion in vegetal oil en-
capsulated form, as in the present study, the CMP exhibits 
anti-oxidant and anti-inflammatory properties in vitro 
and in vivo [24-26]. However the in vivo effects cannot be 
attributed to an absorption of SOD, catalase or other large 
protein molecules because these cannot be absorbed by 
the g.i. tract. Rather, dietary proteins and peptides undergo 
chemical modification and degradation to smaller peptides 
and amino acids when unprotected from the gastric envi-
ronment (low pH, proteases, etc.), so it is not surprising 
that ingestion of unprotected CMP resulted in a loss of 
antioxidant parameters in vivo [19,24] consistent with SOD 
pharmacokinetics [50]. While the encapsulation (protection) 
of CMP protects proteins within the product from acid 
degradation in the stomach, the large protein molecules 
then present within the intestinal environment cannot be 
absorbed by transport systems of the intestinal epitheli-
al cells. Based on this well known physiology, it can be 
concluded that the high SOD and catalase concentrations 
and activities of CMP cannot be directly responsible for 
the increased antioxidant potential in plasma and synovial 
fluid seen in the present study. This raises the question of 
how dietary CMP, when it passes through the stomach and 
enters the intestinal system largely intact, has the ability 
to induce systemic and local upregulation of antioxidant 
parameters. This is a topic of investigation by Lallemand 
(personal communication, Dr. Yannig Letreut, January 
2017). What appears to be the case is that an indirect, and 
as yet unknown mechanism, induces the reported increas-
es in endogenous antioxidant defense systems [24,29,49].
Excessive oxidative stress (levels of ROS that cannot 
be controlled by endogenous activities of oxygen free rad-
ical scavengers such as SOD, catalase and glutathione per-
oxidase) in skeletal muscle is associated with elevations in 
cytosolic calcium and membrane lipid peroxidation [46,51]. 
Membrane lipid peroxidation results in leakage of proteins 
into blood with the time course and magnitude proportion-
al to the amount of muscle damage [52]. The exercise stress 
in the present and related studies [19,29] resulted in evidence 
of muscle damage as indicated by increases in plasma CK 
and AST in horses that did not receive CMP. Twenty-three 
days of supplementation with the blended supplement re-
sulted in plasma CK and AST that were not significantly 
elevated following exercise and there was a tendency to-
wards an upregulation in SF SOD 1 h following exercise 
[23]. The indications of reduced skeletal muscle damage in 
these studies are consistent with the reported antioxidant 
effects of CMP. An additive or synergistic effect of in-
gredients in the blended supplement may account for the 
more definitive antioxidant response seen previously [23].
Post-exercise muscle soreness, stiffness, reduced mus-
cle force production and joint range of motion (DOMS – 
delayed onset muscle soreness) do not become apparent 
until approximately 24 to 48 h following exercise [52]. The 
mitigation of plasma PGE2 24 h following exercise in the 
CMP group suggests CMP supplementation may have aid-
ed in attenuating post-exercise inflammation.
Proteoglycan fragments and increased GAG occur in 
SF following exercise [17] and also occur as a result of 
injury or applied irritants [20,53]. Increased SF GAG con-
centration is a marker of articular cartilage degradation. 
While the mechanism of exercise-induced increases in 
proteoglycan fragments and GAG are not fully under-
stood, excessive mechanical loading [54] and / or inflam-
matory response [20] may be responsible. Thus, the blunted 
increase in post-exercise SF GAG noted in the CMP group 
compared to the Co 1 h post exercise in the current study 
indicates a reduction in cartilage breakdown post exer-
cise. This was associated with evidence for an improved 
antioxidant potential of the synovial environment in CMP 
horses (increased SF SOD in the CMP; reduced SF nitrite 
1 h post exercise). A more comprehensive examination of 
SF markers of antioxidant activity both at rest and follow-
ing exercise are required to understand mechanisms by 
which nutritive antioxidant can mitigate marker of joint 
stress and inflammation.
The regulatory environment for dietary supplements 
differs by country or region. This CMP product has been 
registered and approved for use as an ingredient in animal 
feeds in the EU (under the name Melofeed), as a veteri-
nary health product in Canada (under the name Enzalox) 
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and as an animal supplement in the United States (National 
Animal Supplements Council under the name Enzalox). 
It is important that dietary nutraceutical supplements are 
both safe and effective for the animals for which they are 
intended. The regulatory authorities have agreed that the 
product is safe under the intended conditions of use for 
food production animals and for horses, dogs and cats. 
The present study demonstrates efficacy of the CMP at 
dosages between 1.55 and 2.14 mg / kg body mass for 
horses. 
Duration-response and dose-response studies with the 
CMP product have not been performed using horses, and 
the amount used was recommended on the basis of stud-
ies performed on production animals (cattle, swine) and 
approved for use by the European Food Safety Authority 
(EFSA). The duration selected is typical of that required 
for physiological and biochemical adaptations, although 
the time-course of response remains to be determined. It is 
also possible that a higher dosage may be associated with 
additional physiological benefit. It would also be useful 
to have mode of action studies that specifically examines 
mechanisms by which the supplement exerts the antioxi-
dant effects at the level of muscle and in synovial joints.
5. Summary and Conclusions
Three weeks of supplementation with CMP reduced 
markers of articular and skeletal muscle oxidative stress 
and inflammation in response to high-intensity exercise 
in horses. There was an increase in SF SOD activity, and 
reduced SF nitrite and GAG 1 h following exercise in 
CMP horses. Plasma TAS and LYM levels in CMP horses 
were maintained 1 h following exercise, while PGE2 and 
CK were reduced at 24 h. These data indicate that dietary 
CMP improved the oxidative and inflammatory responses 
following intense exercise. Future studies should seek to 
better characterize mechanisms of action of nutritive an-
tioxidants and their roles in the physiological response to 
demanding exercise.
References
[1] Deaton CM, Marlin DJ. Exercise-associated oxida-
tive stress. Clin Tech Equine Prac., 2004, 2: 278-291.
[2] White SH, Warren LK. Submaximal exercise train-
ing, more than dietary selenium supplementation, 
improves antioxidant status and ameliorates exer-
cise-induced oxidative damage to skeletal muscle in 
young equine athletes. J Anim Sci., 2017, 95: 657-
670.
[3] Mills PC, Smith NC, Ignasi C, et al. Effects of exer-
cise intensity and environmental stress on indices of 
oxidative stress and iron homeostasis during exercise 
in the horse. Eur J Appl Physiol., 1996, 74: 60-66.
[4] Marlin DJ, Fenn K, Smith N, et al. Changes in circu-
latory antioxidant status in horses during prolonged 
exercise. J Nutr., 2002, 132 Suppl 2: 1622S-1627S.
[5] de Moffarts B, Kirschvink N, Art T, et al. Effect of 
exercise on blood oxidant/antioxidant markers in 
standardbred horses: comparison between tread-
mill and race track tests. Equine Vet J, 2006; Suppl 
36:254-257.
[6] de Moffarts B, Kirschvink N, Art T, et al. Effect of 
oral antioxidant supplementation on blood antiox-
idant status in trained thoroughbred horses. Vet J., 
2005, 169: 65-74.
[7] Lamprecht E, Bagnell C, Williams C. Inflammatory 
responses to three modes of intense exercise in Stan-
dardbred mares–a pilot study. Comp Ex Physiol., 
2008, 5: 115-125.
[8] Gondim FJ, Zoppi CC, dos Reis Silveira L, et al. 
Possible relationship between performance and oxi-
dative stress in endurance horses. J Equine Vet Sci., 
2009, 29: 206-212.
[9] Davis JM, Murphy EA, Carmichael MD, Zielinski 
MR, Groschwitz CM, Brown AS, Gangemi JD, Ghaf-
far A, Mayer EP. Curcumin effects on inflammation 
and performance recovery following eccentric ex-
ercise-induced muscle damage. Am J Physiol Regul 
Integr Comp Physiol., 2007, 292(6): R2168-73.
[10] Bazzucchi I, Patrizio F, Ceci R, Duranti G, Sgrò P, 
Sabatini S, Di Luigi L, Sacchetti M, Felici F. The ef-
fects of quercetin supplementation on eccentric exer-
cise-induced muscle damage. Nutrients. 2019, 11(1). 
pii: E205. 
 DOI: 10.3390/nu11010205
[11] Patrizio F, Ditroilo M, Felici F, Duranti G, De Vito 
G, Sabatini S, Sacchetti M, Bazzucchi I. The acute 
effect of Quercetin on muscle performance following 
a single resistance training session. Eur J Appl Physi-
ol., 2018, 118(5): 1021-1031.
[12] Yang SC, Wang CC, Lee SD, Lee YU, Chan KH, YL 
Chen, Fogt DL, Kuo CH. Impact of 12-s rule on per-
formance and muscle damage of baseball pitchers. 
Med Sci Sports Exerc., 2016, 48(12): 2512-2516.
[13] Tanabe Y, Chino K, Ohnishi T, Ozawa H, Sagayama 
H, Maeda S, Takahashi H. Effects of oral curcumin 
ingested before or after eccentric exercise on markers 
of muscle damage and inflammation. Scand J Med 
Sci Sports, 2019, 29(4): 524-534. 
[14] Powers SK, Ji LL, Kavazis AN, Jackson MJ. Re-
active oxygen species: impact on skeletal muscle. 
Compr Physiol., 2011, 1(2): 941-969.
[15] Ranchordas MK, Rogerson D, Soltani H, Costel-
DOI: https://doi.org/10.30564/vsr.v2i1.1559
33
Veterinary Science Research | Volume 02 | Issue 01 | June 2020
Distributed under creative commons license 4.0
lo JT. Antioxidants for preventing and reducing 
muscle soreness after exercise: a Cochrane sys-
tematic review. Br J Sports Med., 2018, 27. pii: 
bjsports-2018-099599.
[16] Reed SR, Jackson BF, Mc Ilwraith CW, et al. De-
scriptive epidemiology of joint injuries in Thorough-
bred racehorses in training. Equine Vet J., 2012, 44: 
13-19.
[17] Fuller CJ, Barr AR, Sharif M, et al. Cross-sectional 
comparison of synovial fluid biochemical markers 
in equine osteoarthritis and the correlation of these 
markers with articular cartilage damage. Osteo & 
Cart, 2001, 9: 49-55.
[18] Frisbie DD, Al-Sobayil F, Billinghurst RC, et al. 
Changes in synovial fluid and serum biomarkers with 
exercise and early osteoarthritis in horses. Osteo & 
Cart, 2008, 16: 1196-204.
[19] Lamprecht ED, Williams CA. Biomarkers of antiox-
idant status, inflammation, and cartilage metabolism 
are affected by acute intense exercise but not super-
oxide dismutase supplementation in horses. Oxid 
Med Cell Long, 2012: 920932. 
 DOI: 10.1155/2012/920932
[20] Pearson W, Orth MW, Lindinger MI. Evaluation of 
inflammatory responses induced via intra-articular 
injection of interleukin-1 in horses receiving a di-
etary nutraceutical and assessment of the clinical 
effects of long-term nutraceutical administration. Am 
J Vet Res., 2009, 70: 848-861.
[21] Henrotin YE, Bruckner P, Pujol JP. The role of reac-
tive oxygen species in homeostasis and degradation 
of cartilage. Osteoarthritis Cartilage, 2003, 11: 747-
755.
[22] Chin KY, Ima-Nirwana S. The role of vitamin E in 
preventing and treating osteoarthritis - a review of 
the current evidence. Front Pharmacol, 2018, 9: 946.
[23] Lindinger MI, MacNicol J, Karrow N, Pearson W. 
Effects of a novel dietary supplement on indices of 
muscle injury and articular GAG release in horses. J 
Equine Vet Sci., 2017, 48: 52-60.
[24] Vouldoukis I, Lacan D, Kamate C, et al. Antioxidant 
and anti-inflammatory properties of a Cucumis melo 
LC. extract rich in superoxide dismutase activity. J 
Ethnopharm, 2004a, 94: 67-75.
[25] Vouldoukis I, Conti M, Krauss P et al. Supplemen-
tation with gliadin-combined plant superoxide dis-
mutase extract promotes antioxidant defences and 
protects against oxidative stress. Phytother Res., 
2004b, 18: 957-962.
[26] Carillon J, Fouret G, Feillet-Coudray C, et al. Short-
term assessment of toxicological aspects, oxidative 
and inflammatory response to dietary melon superox-
ide dismutase in rats. Food Chem Tox, 2013, 5: 323-
328.
[27] Muth CM, Glenz Y, Klaus M, et al. Influence of an 
orally effective SOD on hyperbaric oxygen-related 
cell damage. Free Rad Res., 2004, 38: 927-932.
[28] Lallès JP, D. Lacan D, David JC. A melon pulp con-
centrate rich in superoxide dismutase reduces stress 
proteins along the gastrointestinal tract of pigs. Nutr., 
2011, 27: 358-363.
[29] Webb CB, Lehman TL, McCord KW. Effects of an 
oral superoxide dismutase enzyme supplementation 
on indices of oxidative stress, proviral load, and 
CD4: CD8 ratios in asymptomatic FIV-infected cats. 
J Fel Med Surg., 2008, 10: 423-430.
[30] Naito Y, Akagiri S, Uchiyama K, et al. Reduction of 
diabetes-induced renal oxidative stress by a canta-
loupe melon extract/gliadin biopolymers, oxykine, in 
mice. Biofactors, 2005, 23: 85-95.
[31] Notin C, Vallon L, Desbordes F, et al. Oral supple-
mentation with superoxide dismutase in Standardbred 
trotters in training: a double-blind placebo-controlled 
study. Equine Vet J., 2010, 42, Supplement 38:375-
381.
[32] NRC. Nutrient requirements of horses, Sixth Revised 
Edition. Washington, DC, The National Academies 
Press, 2007. https://nrc88.nas.edu/nrh/ 
[33] Mackenthun E, Coenen M, Vervuert I. Effects of Sac-
charomyces cerevisiae supplementation on apparent 
total tract digestibility of nutrients and fermentation 
profile in healthy horses. J Anim Physiol Anim Nutr 
(Berl), 2013, 97, Suppl 1:115-120.
[34] O’Neill W, S. McKee S, Clare AF. Immunological 
and haematinic consequences of feeding a stan-
dardised Echinacea (Echinacea angustifolia) extract 
to healthy horses. Equine Vet J., 2002, 34: 222-227.
[35] Durkalec-Michalski K, Jeszka J, Odgórski T. The 
effect of a 12-week beta-hydroxy-beta-methylbutyr-
ate (hmb) supplementation on highly-trained combat 
sports athletes: a randomised, double-blind, place-
bo-controlled crossover study. Nutrients, 2017, 9: 
753.
[36] MacNicol JL, Lindinger MI, Pearson W. A time-
course evaluation of inflammatory and oxidative 
markers following high-intensity exercise in horses: 
a pilot study. J Appl Physiol 2018; 124:860-865.
[37] Jayadev C, Rout R, Price A, et al. Hyaluronidase 
treatment of synovial fluid to improve assay precision 
for biomarker research using multiplex immunoassay 
platforms. J Immun Met., 2012, 386: 22-30.
[38] Chandrasekhar S, Esterman MA, Hoffman HA. Mi-
crodetermination of proteoglycans and glycosamino-
glycans in the presence of guanidine hydrochloride. 
DOI: https://doi.org/10.30564/vsr.v2i1.1559
34
Veterinary Science Research | Volume 02 | Issue 01 | June 2020
Distributed under creative commons license 4.0
Anal Biochem, 1987, 161: 103-108.
[39] Gunn, HM. Muscle, bone and fat proportions and 
muscle distribution of Thoroughbreds and other hors-
es. In: Equine Exercise Physiology, 1987, 2: 253-
264.
[40] Zobba R, Ardu M, Niccolini S, et al. Physical, hema-
tological, and biochemical responses to acute intense 
exercise in polo horses. J Equine Vet Sci. 2011, 31: 
542-548.
[41] Piercy RJ, Hinchcliff KW, DiSilvestro RA, et al. Ef-
fect of dietary supplements containing antioxidants 
on attenuation of muscle damage in exercising sled 
dogs. Am J Vet Res., 2000, 61: 1438-1445.
[42] Balogh N, Gaal T, Ribiczeyné PS, et al. Biochemical 
and antioxidant changes in plasma and erythrocytes 
of pentathlon horses before and after exercise. Vet 
Clin Path, 2001, 30: 214-218.
[43] Ficicilar H, Zergeroglu AM, Ersoz G, et al. The ef-
fects of short-term training on platelet functions and 
total antioxidant capacity in rats. Physiol Res. 2006, 
55: 151-156.
[44] Steinberg JG, Delliaux S, Jammes Y. Reliability of 
different blood indices to explore the oxidative stress 
in response to maximal cycling and static exercises. 
Clin Physiol Func Imag. 2006, 26: 106-112.
[45] Barbe F, Sacy A, Bonhommet P, et al. Effect of anti-
oxidant supplementation to horses on muscle integri-
ty and resistance to training. Abstract 18850. 65th an-
nual meeting of the European Federation of Animal 
Science, Copenhagen, Denmark, 2014.
[46] Niess AM, Simon P. Response and adaptation of 
skeletal muscle to exercise--the role of reactive oxy-
gen species. Front Biosci., 2007, 12: 4826-4838.
[47] Trea, F., Ouali, K., Baba-Ahmed, F., Kadi, Y.. La Gli-
sodin®, un extrait de melon, atténue l’apoptose des 
cardiomyocytes via la suppression du stress oxydant 
cardiaque au cours du diabète chronique expérimen-
tal. Phytothérapie, 2013, 6(11): 339-347.
[48] Skarpanska-Stejnborn A, Pilaczynska-Szczesniak L, 
Basta P, et al. Effects of oral supplementation with 
plant superoxide dismutase extract on selected redox 
parameters and an inflammatory marker in a 2,000-m 
rowing-ergometer test. Int J Sports Nutr Ex Metab., 
2011, 21: 124-134.
[49] Romao S. Therapeutic value of oral supplementation 
with melon superoxide dismutase and wheat gliadin 
combination. Nutr., 2015, 31: 430-436.
[50] Regnault C, Soursac M, Roch-Arveiller M, et al. 
Pharmacokinetics of superoxide dismutase in rats af-
ter oral administration. Biopharm Drug Disp., 1996, 
17: 165-174.
[51] Popovic LM, Mitic NR, Radic I, et al. The effect of 
exhaustive exercise on oxidative stress generation 
and antioxidant defense in guinea pigs. Adv Clin Exp 
Med., 2012, 21: 313-320.
[52] Lewis PB, Ruby D, Bush-Joseph CA. Muscle sore-
ness and delayed-onset muscle soreness. Clin Sports 
Med., 2012, 31: 255-262. 
[53] de Grauw JC, Van De Lest CH, Van Weeren PR. 
Inflammatory mediators and cartilage biomarkers in 
synovial fluid after a single inflammatory insult: a 
longitudinal experimental study. Arth Ther. 2009, 11: 
R35-R42.
[54] Roos H, Dahlberg L, Lohmander LS. Proteoglycan 
fragments in knee joint fluid after exercise. Scand J 
Med Sci Sports, 1993, 3: 127-130. 
DOI: https://doi.org/10.30564/vsr.v2i1.1559
